Bioinformatics of Non Small Cell Lung Cancer and the Ras Proto-Oncogene (Record no. 53284)

000 -LEADER
fixed length control field 03262nam a22006015i 4500
001 - CONTROL NUMBER
control field 978-981-4585-08-8
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20200420221303.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 140908s2015 si | s |||| 0|eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9789814585088
-- 978-981-4585-08-8
082 04 - CLASSIFICATION NUMBER
Call Number 006.3
100 1# - AUTHOR NAME
Author Kashyap, Amita.
245 10 - TITLE STATEMENT
Title Bioinformatics of Non Small Cell Lung Cancer and the Ras Proto-Oncogene
300 ## - PHYSICAL DESCRIPTION
Number of Pages VII, 72 p. 40 illus., 39 illus. in color.
490 1# - SERIES STATEMENT
Series statement SpringerBriefs in Applied Sciences and Technology,
505 0# - FORMATTED CONTENTS NOTE
Remark 2 Introduction -- Review of Literature -- Materials and Methods (Tools and Databases) -- Flowchart -- Conclusion.-References.
520 ## - SUMMARY, ETC.
Summary, etc Cancer is initiated by activation of oncogenes or inactivation of tumor suppressor genes. Mutations in the K-ras proto-oncogene are responsible for 10-30% of adenocarcinomas. Clinical Findings point to a wide variety of other cancers contributing to lung cancer incidence. Such a scenario makes identification of lung cancer difficult and thus identifying its mechanisms can contribute to the society. Identifying unique conserved patterns common to contributing proto-oncogenes may further be a boon to Pharmacogenomics and pharmacoinformatics. This calls for ab initio/de novo drug discovery that in turn will require a comprehensive in silico approach of Sequence, Domain, Phylogenetic and Structural analysis of the receptors, ligand screening and optimization and detailed Docking studies. This brief involves extensive role of the RAS subfamily that includes a set of proteins, which cause an over expression of cancer-causing genes like M-ras and initiate tumour formation in lungs. SNP Studies and Structure based drug discovery will also be undertaken.
700 1# - AUTHOR 2
Author 2 Bujamma, D.
700 1# - AUTHOR 2
Author 2 Babu M, Naresh.
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier http://dx.doi.org/10.1007/978-981-4585-08-8
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type eBooks
264 #1 -
-- Singapore :
-- Springer Singapore :
-- Imprint: Springer,
-- 2015.
336 ## -
-- text
-- txt
-- rdacontent
337 ## -
-- computer
-- c
-- rdamedia
338 ## -
-- online resource
-- cr
-- rdacarrier
347 ## -
-- text file
-- PDF
-- rda
650 #0 - SUBJECT ADDED ENTRY--SUBJECT 1
-- Engineering.
650 #0 - SUBJECT ADDED ENTRY--SUBJECT 1
-- Cancer research.
650 #0 - SUBJECT ADDED ENTRY--SUBJECT 1
-- Health informatics.
650 #0 - SUBJECT ADDED ENTRY--SUBJECT 1
-- Bioinformatics.
650 #0 - SUBJECT ADDED ENTRY--SUBJECT 1
-- Applied mathematics.
650 #0 - SUBJECT ADDED ENTRY--SUBJECT 1
-- Engineering mathematics.
650 #0 - SUBJECT ADDED ENTRY--SUBJECT 1
-- Computational intelligence.
650 #0 - SUBJECT ADDED ENTRY--SUBJECT 1
-- Biomedical engineering.
650 14 - SUBJECT ADDED ENTRY--SUBJECT 1
-- Engineering.
650 24 - SUBJECT ADDED ENTRY--SUBJECT 1
-- Computational Intelligence.
650 24 - SUBJECT ADDED ENTRY--SUBJECT 1
-- Computational Biology/Bioinformatics.
650 24 - SUBJECT ADDED ENTRY--SUBJECT 1
-- Cancer Research.
650 24 - SUBJECT ADDED ENTRY--SUBJECT 1
-- Biomedical Engineering.
650 24 - SUBJECT ADDED ENTRY--SUBJECT 1
-- Health Informatics.
650 24 - SUBJECT ADDED ENTRY--SUBJECT 1
-- Appl.Mathematics/Computational Methods of Engineering.
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
-- 2191-530X
912 ## -
-- ZDB-2-ENG

No items available.